Table 1.
Relevant miRNAs and targets previously identified in the literature and associated with IBS pathophysiology in clinical and animal studies.
mRNA |
miRNA |
||||
Group |
Up |
Down |
Up |
Down |
Biological role |
Cluster 1 | Srf | miR-143-3p | GI motility26 | ||
Slc6a4 (Sert) | miR-200a-3p | Visceral hyperalgesia27 | |||
Aqp3 | miR-29a-3p | Intestinal permeability28 | |||
Pten | miR-21-5p | Intestinal barrier function29 | |||
Cdh1 | miR-219a-5p | Intestinal barrier function and visceral nociception30 | |||
Cacna1c | miR-342-3p | Colonic motility, pain signaling, and smooth muscle function31 | |||
miR-338-3p | Intestinal permeability and visceral nociception30 | ||||
Aqp8 | miR-29a-3p | Intestinal permeability28 | |||
Ocln | miR-122-5p | Intestinal barrier function32 | |||
Myocd | Regulation of GI smooth muscle cell phenotype26 | ||||
Tjp1 (ZO-1) |
miR-29a-3p | miR-219a-5p | Intestinal barrier function30,33 | ||
Pkib | Visceral sensitivity34 | ||||
Prdx1 | LPS-induced inflammatory damage35 | ||||
miR-106b-5p | Mapk signaling pathway36 | ||||
miR-148a-3p | IBS-D symptoms37 | ||||
miR-190a-5p | IBS-D symptoms37 | ||||
miR-194-5p | IBS-D symptoms37 |